Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Angiolillo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Hematology|October 28, 1999
Long-term treatment of refractory thrombocytopenia in a patient with Wiskott-Aldrich syndrome with vincristine, immunoglobulin, and methylprednisoloneG Young, A L Angiolillo
Blood|May 1, 1996
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10C Sgadari, A L Angiolillo, G Tosato
Annals of the New York Academy of Sciences|October 31, 1996
A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12A L Angiolillo, C Sgadari, G Tosato
Immunogenetics|January 1, 1986
An evolutionary conserved rabbit T-cell receptor beta-chain variable regionE Lamoyi, A L Angiolillo, R G Mage
Bailliere'S Clinical Haematology|March 1, 1995
Epstein-Barr virus as an agent of haematological diseaseG Tosato, K Taga, A L Angiolillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1985
Identification of genes for the constant region of rabbit T-cell receptor beta chainsA L Angiolillo, E Lamoyi, K E Bernstein, et al.
Leukemia & Lymphoma|October 1, 1995
Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus-immortalized B cellsA L Angiolillo, C Sgadari, N Sheikh, et al.
Biochemical and Biophysical Research Communications|April 7, 1997
Interleukin-15 promotes angiogenesis in vivoA L Angiolillo, H Kanegane, C Sgadari, et al.
Pediatric Blood & Cancer|March 30, 2004
Staged informed consent for a randomized clinical trial in childhood leukemia: impact on the consent processA L Angiolillo, C Simon, E Kodish, et al.
The Journal of Experimental Medicine|July 1, 1995
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivoA L Angiolillo, C Sgadari, D D Taub, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Hematology|October 28, 1999
Long-term treatment of refractory thrombocytopenia in a patient with Wiskott-Aldrich syndrome with vincristine, immunoglobulin, and methylprednisoloneG Young, A L Angiolillo
Blood|May 1, 1996
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10C Sgadari, A L Angiolillo, G Tosato
Annals of the New York Academy of Sciences|October 31, 1996
A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12A L Angiolillo, C Sgadari, G Tosato
Immunogenetics|January 1, 1986
An evolutionary conserved rabbit T-cell receptor beta-chain variable regionE Lamoyi, A L Angiolillo, R G Mage
Bailliere'S Clinical Haematology|March 1, 1995
Epstein-Barr virus as an agent of haematological diseaseG Tosato, K Taga, A L Angiolillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1985
Identification of genes for the constant region of rabbit T-cell receptor beta chainsA L Angiolillo, E Lamoyi, K E Bernstein, et al.
Leukemia & Lymphoma|October 1, 1995
Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus-immortalized B cellsA L Angiolillo, C Sgadari, N Sheikh, et al.
Biochemical and Biophysical Research Communications|April 7, 1997
Interleukin-15 promotes angiogenesis in vivoA L Angiolillo, H Kanegane, C Sgadari, et al.
Pediatric Blood & Cancer|March 30, 2004
Staged informed consent for a randomized clinical trial in childhood leukemia: impact on the consent processA L Angiolillo, C Simon, E Kodish, et al.
The Journal of Experimental Medicine|July 1, 1995
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivoA L Angiolillo, C Sgadari, D D Taub, et al.
Pageof 2